Connect with us

News

CVS to Sell CBD Products in Eight States

Avatar

Published

on

CVS Health Corp. announced on March 20 that it intends to sell cannabidiol (CBD) products in 800 stores across eight states, as part of a distribution deal with Curaleaf Holdings Inc. The announcement sent Curaleaf’s stocks soaring, according to Bloomberg.

CVS is expected to begin to carry Curaleaf Hemp lotions and transdermal patches infused with CBD. CVS will be selling the products in Alabama, California, Colorado, Illinois, Indiana, Kentucky, Maryland and Tennessee. This pivotal moment is highlighted by the fact that CVS is the largest drugstore in America by total prescription sales revenue. The company has opened nearly 10,000 pharmacy locations. The company will also reportedly sell products from Axcentria’s Elevate CBD brand.

“These products include topicals such as creams, sprays, roll-ons, lotions and salves. We are not selling any CBD-containing supplements or food additives.  We have partnered with CBD product manufacturers that are complying with applicable laws and that meet CVS’s high standards for quality,” CVS said in a statement.

On CNBC, in an interview with Jim Cramer, CVS CEO Larry Merlo said the decision was based on a number of personal anecdotes from countless customers who say they have found relief for arthritis, pain and other issues. Merlo also said that CVS isn’t selling CBD products at the moment, although that could change very shortly if the company’s plans pan out.

Following the announcement, Curaleaf’s stock soared 17 percent in Canadian markets. Curaleaf operates over 40 dispensaries spanning 12 states. The company’s profile of products now includes vape pens, patches, tinctures and lotions.

While The U.S. Food and Drug Administration maintains that CBD is a drug ingredient, and unproven health claims cannot be made, the latest Farm Bill opened up the doors to CBD reform, with varying degrees of interpretation. Forty-seven states, Puerto Rico and Washington D.C. have loosened CBD laws. The products could be available in stores by Friday and through the CVS website shortly.

 

News

Strain of the Week: Midnite

Avatar

Published

on

Whoever first said that “nothing good happens after midnight” clearly was not enjoying life. Maybe it was said to perpetuate safety, specifically toward rambunctious youth who went gallivanting around in the forest at night. Or maybe it was more geared toward superstitious beliefs about witches or paranormal entities who roam around when the sun goes down. Either way, whoever said it definitely hadn’t seen a Gremlins movie, which contrary to the plot which warns against feeding a Gremlin at night, is one of the weirdest and best 1980s movies ever (change our mind). Ultimately though, cannabis after midnight can be a treat, especially when it’s a strain like Midnite.

Midnite is a cross between Bubba Kush and Chem #4. Bubba Kush is well-known for its earthiness, deep pine aroma and ability to induce sleep (not to mention that, as reviewers put it, it’s so widely loved that consuming it is often like “greeting an old friend at the airport”). Chem #4, which is also short for Chemdog/Chemdawg, is a zesty hybrid, complete with scents and flavors of lemon, that delivers full body effects of relaxation and euphoria. Between these two powerhouse strains create a unique strain child that’s full of potential.

Described as light green and denser than a dogwood tree, Midnite strain samples were absolutely covered in frosty trichomes—so much that it almost seemed like it was covered in freshly fallen snow, or even might glow when placed in a dark place. Surprisingly, the bud didn’t have much of a scent until it was ground up, revealing a potent chemmy aroma that made our seasoned reviewers salivate. Upon inhalation, the flower was robust but not harsh, leading to full body relaxation that didn’t feel lethargic. It won’t stop anyone from getting a full night’s sleep when ready to crash, however, and the rest of its qualities were deep and relaxing.

Continue Reading

News

Virginia to Focus on Legal Cannabis in 2021 Legislative Session

Avatar

Published

on

Some legislators in Virginia are planning on pushing for support to consider recreational cannabis this year.

The 2021 legislative session in Virginia, which began on January 13, will be conducted remotely as the pandemic continues to be a major concern. The state’s House of Delegates will be meeting entirely remotely, and the Vermont Senate will meet at a conference center instead of at the state capitol building.

To start off this year’s legislative session, there are multiple topics on the table for discussion, including COVID-19 relief and the death penalty repeal. But perhaps the most contentious issue of all is the discussion of recreational cannabis legalization.

During this legislative push, Governor Ralph Northam is once again making it known that he would like to see recreational cannabis legalized. If Virginia legislators make a move, they will be the first Southern state to fully legalize cannabis. Currently, the state only allows medical cannabis, which went into effect on July 1, 2020.

Northam, who has been speaking out in favor of recreational legalization since November 2020, would like to see a legal approach that makes sure youth safety is high priority and also prioritizes the struggle of marginalized people disproportionately affected by the War on Drugs.

The success of this push for legalization will hinge on whether or not there are enough votes in the legislature in favor of legal cannabis for it to pass. However, even Republicans are coming around to cannabis issues in many states, and Virginia has successfully decriminalized cannabis and legalized a medical program.

Despite the fact that the state has already laid the groundwork for full, recreational legalization, it remains to be seen whether Virginia will follow through and successfully legalize cannabis this year.

Continue Reading

News

WSU Study Finds Cannabis May Diminish Stress Response

Avatar

Published

on

A new study from Washington State University (WSU) has found that cannabis may diminish a user’s physiological response to stress.

Researchers found female rats that self-administered daily puffs of cannabis vapor for a month had lower blood levels of a hormone that causes stress when presented with a stressful situation than they did at the beginning of the experiment and compared to a control group. The rats were trained to trigger an infrared sensor that would activate a puff of cannabis vapor anytime they felt the urge. Previous studies have shown cannabis could have an effect on stress response.

After 30 days, only female rats that had access to the cannabis had a significantly muted response to stress. The rats that were given access to cannabis also tended to respond more for the substance and had higher concentrations in their blood after the experiment. Male rats did not experience the same results, but they also self-administered a lot less.  

“We don’t know if this is a good thing or a bad thing and there’s reason to argue for either of them at this point—a blunted stress response might actually predispose some people to certain mental health conditions is our concern,” said co-author of the study and WSU assistant professor of psychology, Carrie Cuttler. “So yeah, it sounds great on the surface that maybe they’re less prone to stress…but the stress response is an important system that exists for a reason—any alterations in that or perturbations in that system may or may not be a good thing.”

WSU assistant professor and another co-author of the study, Ryan McClain, mentioned there are ethical and legal concerns with testing stress responses on humans, as well as administering cannabis to some of the human participants, so these kinds of studies are limited to animal models.

Continue Reading

Newsletter

Trending